Prospective Evaluation of a Modified Apnea Test in Brain Death Candidates that Does Not Require Disconnection from the Ventilator.

Johann LambeckJürgen BardutzkyChristoph StreckerWolf-Dirk Niesen

Published in: Neurocritical care (2024)

The mAT is a safe and protective means of identifying patients who no longer have an intact central respiratory drive, which is a critical factor in the diagnosis of BD/DNC. Clinical trial registration DRKS, DRKS00017803, retrospectively registered 23.11.2020, https://drks.de/search/de/trial/DRKS00017803.

Keyphrases

clinical trial
phase ii
study protocol
phase iii
obstructive sleep apnea
white matter
acute respiratory distress syndrome
intensive care unit
double blind
brain injury
subarachnoid hemorrhage
cerebral ischemia